Showing results (81-90 of 566) with videos related to
Sort By:
Pageof 57
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphomaP Borchmann, R Schnell, R Knippertz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2013
Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: an analysis of international staging definitionsB Klimm, H Goergen, M Fuchs, et al.Cancer Research|December 1, 1994
Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse modelC Gottstein, G Schön, S Tawadros, et al.Nuklearmedizin. Nuclear Medicine|February 26, 2003
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects]J O Staak, M Dietlein, A Engert, et al.Annals of Hematology|April 23, 2003
Clinical applications of granulocyte colony-stimulating factor: an update and summaryK Hübel, A EngertOnkologie|March 8, 2003
Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapyK Hübel, A EngertAnnals of Hematology|May 10, 2000
Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomyH Schäfer, K Hübel, H Bohlen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Is Hodgkin's disease an infectious disease?J Wolf, V DiehlPageof 57